|
Quotes & Info
|
| MRNA > SEC Filings for MRNA > Form 8-K on 23-Jun-2009 | All Recent SEC Filings |
23-Jun-2009
Other Events
On June 22, 2009, MDRNA, Inc. (the "Company") received a letter from The NASDAQ Stock Market, LLC ("NASDAQ") notifying the Company that is has regained full compliance with all requirements for remaining on The NASDAQ Global Market, including, specifically, NASDAQ Marketplace Rule 5450(b)(2) (the "market value standard"), which requires, among other things, a minimum market value of listed securities of $50.0 million (NASDAQ Marketplace Rule 5450(b)(2)(A)). Accordingly, the NASDAQ Listing Qualifications Panel has determined to continue the listing of the Company's common stock on The NASDAQ Global Market.
The Company announced the receipt of the letter from NASDAQ in a press release dated June 23, 2009, a copy of which is attached as Exhibit 99.1 hereto.
|
|